Library

3-EtO-PCP

3-EtO-PCP is a novel arylcyclohexylamine with an ethoxy substituent at the 3-position of the phenyl ring, making it a heavier and more lipophilic analogue of 3-MeO-PCP. User reports suggest strong dissociation with a sedating, muddy headspace more similar to DCK than the manic clarity of 3-MeO-PCP. Insufflation causes severe nasal pain and prolonged throat irritation; oral or sublingual administration is recommended. Due to its novelty, no peer-reviewed pharmacokinetic data exists. By structural analogy to other PCP derivatives, tolerance develops rapidly, cross-tolerance occurs with all dissociatives, and reagent testing plus ideally GC-MS confirmation is essential before use.

Also known as: 3-ethoxy-PCP, 3-OEt-PCP

Classification

  • Chemical: Arylcyclohexylamine
  • Psychoactive: Dissociative
  • Tag: Hallucinogen
  • Tag: Research-Chemical

Effects

  • Pain Relief
  • Sedation
  • Nystagmus
  • Residual Stimulation
  • Numbness
  • Stimulation
  • Dissociative Anesthesia
  • Cognitive Euphoria
  • Depersonalization
  • Derealization
  • Motor Control Loss
  • Time Distortion
  • Spatial Disorientation
  • Tactile Suppression
  • Visual Disconnection
  • Open Eye Visuals
  • Double Vision
  • Disinhibition

Routes of Administration

Oral

Dosage

  • Threshold: 20-30 mg
  • Light: 30-50 mg
  • Common: 50-80 mg
  • Strong: 80-120 mg
  • Heavy: 120+ mg

Duration

  • Onset: 0.5-0.75 h
  • Peak: 1.5-3 h
  • Offset: 2-4 h
  • After Effects: 5-12 h
  • Total Duration: 6-8 h

Insufflated

Dosage

  • Threshold: 10 mg
  • Light: 10-25 mg
  • Common: 25-50 mg
  • Strong: 50-80 mg
  • Heavy: 80+ mg

Duration

  • Onset: 0.17-0.33 h
  • Peak: 1-3 h
  • Offset: 2-4 h
  • After Effects: 5-12 h
  • Total Duration: 6-7 h

Vaporized / Smoked

Dosage

  • Threshold: 5 mg (free-base)
  • Light: 5–15 mg (free-base)
  • Common: 15–30 mg (free-base)
  • Strong: 30–50 mg (free-base)
  • Heavy: 50+ mg (free-base)

Duration

  • Onset: 0.02-0.08 h
  • Peak: 1-2 h
  • Offset: 2-3 h
  • After Effects: 4-8 h

Harm Reduction

Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.

Sources

Substance data is aggregated from the following public harm-reduction and reference sources.

Links

This static page is intended as a readable non-JS and prerender-friendly library export.

Get the full DrugsPRO experience

Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.

Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu

3-EtO-PCP - מדריך חומרים של DrugsPRO

3-EtO-PCP: 3-EtO-PCP is a novel arylcyclohexylamine with an ethoxy substituent at the 3-position of the phenyl ring, making it a heavier and more lipophilic analogue of 3-MeO-PCP. User reports suggest strong dissociation with a sedating, muddy headspace more similar to DCK than the manic clarity of

Related pages